(Q84345502)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19653335%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

review article

1 reference

title

Post-infectious irritable bowel syndrome (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19653335%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

main subject

irritable bowel syndrome

1 reference

Marroon Thabane

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19653335%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

John K Marshall

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19653335%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

publication date

1 August 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19653335%20AND%20SRC:MED&resulttype=core&format=json

World Journal of Gastroenterology

4 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19653335%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19653335%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

issue

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19653335%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

page(s)

3591-3596

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19653335%20AND%20SRC:MED&resulttype=core&format=json

Intestinal permeability in patients with irritable bowel syndrome after a waterborne outbreak of acute gastroenteritis in Walkerton, Ontario

4 February 2020

cites work

1 reference

12 December 2020

Tegaserod is effective in the initial and retreatment of irritable bowel syndrome with constipation

1 reference

12 December 2020

A dose-ranging, phase II study of the efficacy and safety of alosetron in men with diarrhea-predominant IBS.

1 reference

12 December 2020

Post-infectious irritable bowel syndrome in patients with Shigella infection

1 reference

12 December 2020

Probiotics and irritable bowel syndrome: rationale, mechanisms, and efficacy

1 reference

12 December 2020

The use of probiotics in the prevention and treatment of antibiotic-associated diarrhea with special interest in Clostridium difficile-associated diarrhea

1 reference

12 December 2020

The clinical course of postinfectious irritable bowel syndrome: a five-year follow-up study.

1 reference

12 December 2020

Alosetron relieves pain and improves bowel function compared with mebeverine in female nonconstipated irritable bowel syndrome patients

1 reference

12 December 2020

A double-blind, randomized, placebo-controlled dose-ranging study to evaluate the efficacy of alosetron in the treatment of irritable bowel syndrome

1 reference

12 December 2020

Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial

1 reference

12 December 2020

Rifaximin versus chlortetracycline in the short-term treatment of small intestinal bacterial overgrowth.

1 reference

12 December 2020

Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome

1 reference

12 December 2020

Effect of fermented milk containing probiotic bacteria in the prevention of an enteroinvasive Escherichia coli infection in mice.

1 reference

12 December 2020

Dyspepsia and irritable bowel syndrome after a Salmonella gastroenteritis outbreak: one-year follow-up cohort study.

1 reference

12 December 2020

A randomised controlled trial assessing the efficacy and safety of repeated tegaserod therapy in women with irritable bowel syndrome with constipation

1 reference

12 December 2020

Enterochromaffin cell hyperplasia and decreased serotonin transporter in a mouse model of postinfectious bowel dysfunction

1 reference

12 December 2020

Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice

1 reference

12 December 2020

Probiotics and irritable bowel syndrome: rationale, putative mechanisms, and evidence of clinical efficacy

1 reference

12 December 2020

[The development of irritable bowel syndrome after Shigella infection: 3 year follow-up study].

1 reference

12 December 2020

The functional gastrointestinal disorders and the Rome III process

1 reference

12 December 2020

To "lump" or to "split" the functional somatic syndromes: can infectious and emotional risk factors differentiate between the onset of chronic fatigue syndrome and irritable bowel syndrome?

1 reference

12 December 2020

The incidence of irritable bowel syndrome among community subjects with previous acute enteric infection.

1 reference

12 December 2020

Incidence and epidemiology of irritable bowel syndrome after a large waterborne outbreak of bacterial dysentery.

1 reference

12 December 2020

Is traveler's diarrhea a significant risk factor for the development of irritable bowel syndrome? A prospective study

1 reference

12 December 2020

Postinfectious irritable bowel syndrome after a food-borne outbreak of acute gastroenteritis attributed to a viral pathogen

1 reference

12 December 2020

Risk of irritable bowel syndrome after an episode of bacterial gastroenteritis in general practice: influence of comorbidities

1 reference

12 December 2020

Irritable bowel syndrome in persons who acquired trichinellosis

1 reference

12 December 2020

The cognitive behavioural model of irritable bowel syndrome: a prospective investigation of patients with gastroenteritis

1 reference

12 December 2020

Systematic review and meta-analysis: The incidence and prognosis of post-infectious irritable bowel syndrome

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled study to assess efficacy and safety of 0.5 mg and 1 mg alosetron in women with severe diarrhea-predominant IBS.

1 reference

12 December 2020

Effect of tegaserod on recto-sigmoid tonic and phasic activity in constipation-predominant irritable bowel syndrome.

1 reference

12 December 2020

Effect of tegaserod on colonic transit time in male patients with constipation-predominant irritable bowel syndrome.

1 reference

12 December 2020

Safety, tolerability and satisfaction with tegaserod therapy in Asia-Pacific patients with irritable bowel syndrome with constipation

1 reference

12 December 2020

Low risk of irritable bowel syndrome after Clostridium difficile infection

1 reference

12 December 2020

Development of functional diarrhea, constipation, irritable bowel syndrome, and dyspepsia during and after traveling outside the USA.

1 reference

12 December 2020

Tegaserod for female patients suffering from IBS with mixed bowel habits or constipation: a randomized controlled trial

1 reference

12 December 2020

Effect of Lactobacillus casei as a probiotic on modulation of giardiasis

1 reference

12 December 2020

Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome

1 reference

12 December 2020

Role of immunologic factors and cyclooxygenase 2 in persistent postinfective enteric muscle dysfunction in mice

1 reference

12 December 2020

A randomized controlled clinical trial of the serotonin type 3 receptor antagonist alosetron in women with diarrhea-predominant irritable bowel syndrome

1 reference

12 December 2020

Tegaserod, a 5-HT(4) receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation

1 reference

12 December 2020

Irritable bowel syndrome prevalence varies enormously depending on the employed diagnostic criteria: comparison of Rome II versus previous criteria in a general population

1 reference

12 December 2020

Prognosis in post-infective irritable bowel syndrome: a six year follow up study.

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled trial of tegaserod in female patients suffering from irritable bowel syndrome with constipation

1 reference

12 December 2020

Increased rectal mucosal expression of interleukin 1beta in recently acquired post-infectious irritable bowel syndrome

1 reference

12 December 2020

Post-traveler's diarrhea irritable bowel syndrome: a prospective study

1 reference

12 December 2020

An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome

1 reference

12 December 2020

Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC)

1 reference

12 December 2020

Randomized, double-blind, placebo-controlled trial of prednisolone in post-infectious irritable bowel syndrome

1 reference

12 December 2020

Distinctive clinical, psychological, and histological features of postinfective irritable bowel syndrome

1 reference

12 December 2020

Psychopathology in irritable bowel syndrome: support for a psychophysiological model

1 reference

12 December 2020

Does bacterial gastroenteritis predispose people to functional gastrointestinal disorders? A prospective, community-based, case-control study

1 reference

12 December 2020

Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS.

1 reference

12 December 2020

A double-blind, placebo-controlled, randomized study to evaluate the efficacy, safety and tolerability of tegaserod in patients with irritable bowel syndrome

1 reference

12 December 2020

Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome.

1 reference

12 December 2020

Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis

1 reference

12 December 2020

Effect of alosetron on bowel urgency and global symptoms in women with severe, diarrhea-predominant irritable bowel syndrome: analysis of two controlled trials

1 reference

12 December 2020

Post-diarrhea chronic intestinal symptoms and irritable bowel syndrome in North American travelers to Mexico.

1 reference

12 December 2020

Lactobacillus paracasei normalizes muscle hypercontractility in a murine model of postinfective gut dysfunction

1 reference

12 December 2020

1 reference

12 December 2020

Gut Propulsion in Mice Infected with Trichinella spiralis

1 reference

12 December 2020

Irritable bowel syndrome--post salmonella infection

1 reference

12 December 2020

Psychometric scores and persistence of irritable bowel after infectious diarrhoea.

1 reference

12 December 2020

Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: postal survey of patients

1 reference

12 December 2020

The role of psychological and biological factors in postinfective gut dysfunction

1 reference

12 December 2020

Increased risk of irritable bowel syndrome after bacterial gastroenteritis: cohort study

1 reference

12 December 2020

Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5-HT3 receptor antagonist

1 reference

12 December 2020

Antibiotic efficacy in small intestinal bacterial overgrowth-related chronic diarrhea: a crossover, randomized trial

1 reference

12 December 2020

The irritable colon syndrome. A study of the clinical features, predisposing causes, and prognosis in 130 cases

1 reference

12 December 2020

Post-dysenteric colitis.

1 reference

12 December 2020

Long-term safety and efficacy of alosetron in women with severe diarrhea-predominant irritable bowel syndrome

1 reference

12 December 2020

Identifiers

DOI

10.3748/WJG.15.3591

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19653335%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19653335%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

PubMed publication ID

19653335

1 reference